nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer
|
Liu, Xinlin |
|
|
239 |
C |
p. |
artikel |
2 |
Advances in understanding cancer-associated neurogenesis and its implications on the neuroimmune axis in cancer
|
Yaman, Ismail |
|
|
239 |
C |
p. |
artikel |
3 |
Clinical advances in oncolytic virotherapy for pediatric brain tumors
|
Ghajar-Rahimi, Gelare |
|
|
239 |
C |
p. |
artikel |
4 |
Clinical implications of tristetraprolin (TTP) modulation in the treatment of inflammatory diseases
|
Snyder, Brittany L. |
|
|
239 |
C |
p. |
artikel |
5 |
Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends
|
Song, Sheng-Lei |
|
|
239 |
C |
p. |
artikel |
6 |
Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeutics
|
Yang, Jian |
|
|
239 |
C |
p. |
artikel |
7 |
Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation
|
Raut, Sanket B. |
|
|
239 |
C |
p. |
artikel |
8 |
Editorial Board
|
|
|
|
239 |
C |
p. |
artikel |
9 |
Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities
|
Shao, Shiying |
|
|
239 |
C |
p. |
artikel |
10 |
Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors
|
Sugahara, Mai |
|
|
239 |
C |
p. |
artikel |
11 |
Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives
|
Ferrari, Federica |
|
|
239 |
C |
p. |
artikel |
12 |
Inflammation and oxidative stress as mediators of the impacts of environmental exposures on human pregnancy: Evidence from oxylipins
|
Welch, Barrett M. |
|
|
239 |
C |
p. |
artikel |
13 |
Mitochondrial metabolism mediated macrophage polarization in chronic lung diseases
|
Dong, Ting |
|
|
239 |
C |
p. |
artikel |
14 |
Novel strategies exploiting interleukin-12 in cancer immunotherapy
|
Cirella, Assunta |
|
|
239 |
C |
p. |
artikel |
15 |
Regulation of feeding and therapeutic application of bioactive peptides
|
Ueno, Hiroaki |
|
|
239 |
C |
p. |
artikel |
16 |
Review of the application of Kirchhoff's Laws of series and parallel flows to pharmacology: Defining organ clearance
|
Pachter, Jonathan Asher |
|
|
239 |
C |
p. |
artikel |
17 |
Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases
|
Ikeda, Takako |
|
|
239 |
C |
p. |
artikel |
18 |
Stress- and drug-induced neuroimmune signaling as a therapeutic target for comorbid anxiety and substance use disorders
|
Smiley, Cora E. |
|
|
239 |
C |
p. |
artikel |
19 |
Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
|
Li, Si Han |
|
|
239 |
C |
p. |
artikel |
20 |
The future of targeted kinase inhibitors in melanoma
|
Caksa, Signe |
|
|
239 |
C |
p. |
artikel |
21 |
The IL-18/IL-18R1 signalling axis: Diagnostic and therapeutic potential in hypertension and chronic kidney disease
|
Thomas, Jordyn M. |
|
|
239 |
C |
p. |
artikel |
22 |
The mystery of the human proton-organic cation antiporter: One transport protein or many?
|
Sachkova, Alexandra |
|
|
239 |
C |
p. |
artikel |
23 |
Therapeutics targeting the metastatic breast cancer bone microenvironment
|
Ihle, Claire L. |
|
|
239 |
C |
p. |
artikel |
24 |
The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future
|
Zhao, Jiuliang |
|
|
239 |
C |
p. |
artikel |